Get the Stockscreener App
21.18
3.17%
0.65
Xoma Royalty Corp stock is traded at $21.18, with a volume of 14,845.
It is up +3.17% in the last 24 hours and up +2.17% over the past month.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
See More
Previous Close:
$20.53
Open:
$20.64
24h Volume:
14,845
Relative Volume:
0.40
Market Cap:
$242.40M
Revenue:
$9.71M
Net Income/Loss:
$-29.96M
P/E Ratio:
-6.0862
EPS:
-3.48
Net Cash Flow:
$-14.79M
1W Performance:
+7.51%
1M Performance:
+2.17%
6M Performance:
-26.56%
1Y Performance:
-12.66%
1-Day Range:
$20.59
$21.58
1-Week Range:
$19.38
$21.58
52-Week Range:
$18.35
$35.00
Xoma Royalty Corp Stock (XOMA) Company Profile
Name
Xoma Royalty Corp
Sector
Industry
Phone
510-204-7239
Address
2200 POWELL STREET, EMERYVILLE, CA
Compare XOMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
21.18 | 242.40M | 9.71M | -29.96M | -14.79M | -3.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | The Benchmark Company | Buy |
| Apr-29-24 | Initiated | Leerink Partners | Outperform |
| Sep-07-21 | Downgrade | Wedbush | Outperform → Neutral |
| Jun-29-21 | Initiated | Aegis Capital | Buy |
| Jan-19-21 | Reiterated | H.C. Wainwright | Buy |
| Jan-18-18 | Reiterated | H.C. Wainwright | Buy |
| Oct-17-17 | Resumed | H.C. Wainwright | Buy |
| Sep-05-17 | Upgrade | Wedbush | Neutral → Outperform |
| Jun-12-17 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-11-16 | Reiterated | Wedbush | Outperform |
| Jul-23-15 | Downgrade | Jefferies | Buy → Hold |
| Jul-22-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-22-15 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Oct-10-14 | Resumed | ROTH Capital | Buy |
| Apr-29-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-11-14 | Downgrade | MLV & Co | Buy → Hold |
| Mar-05-14 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-31-13 | Reiterated | MLV & Co | Buy |
| May-09-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-14-12 | Initiated | Cowen & Co | Outperform |
| Mar-31-11 | Reiterated | MLV Capital | Buy |
| Mar-23-11 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-06-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jan-04-11 | Reiterated | Wedbush | Outperform |
View All
Xoma Royalty Corp Stock (XOMA) Latest News
Benchmark Begins Coverage on XOMA (NASDAQ:XOMA) - Defense World
Benchmark Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq
Benchmark Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq
XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World
Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals
Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals
XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability - Yahoo Finance
XOMA completes sale of Kinnate assets for up to $270 million - Investing.com Australia
Xoma Royalty Completes Sale Of Kinnate Pipeline Assets - MarketScreener
XOMA Royalty Completes Sale of Kinnate Pipeline Assets - GlobeNewswire
XOMA Co. (NASDAQ:XOMA) Director Joseph M. Limber Buys 17,935 Shares - MarketBeat
XOMA (NASDAQ:XOMA) Stock Rating Upgraded by StockNews.com - Defense World
XOMA Royalty Corp’s chief investment officer purchases $49,400 in depositary shares By Investing.com - Investing.com Canada
CIO’s Bold Move: A Major Investment in Xoma Stock - TipRanks
XOMA Royalty Corp's chief investment officer purchases $49,400 in depositary shares By Investing.com - Investing.com India
XOMA Royalty Corp Officer Acquires Additional Shares - TradingView
XOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
20 Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist - Seeking Alpha
Director Makes Bold Move with Major Xoma Stock Purchase - TipRanks
XOMA stock touches 52-week low at $18.59 amid market shifts - Investing.com Australia
XOMA stock touches 52-week low at $18.59 amid market shifts By Investing.com - Investing.com South Africa
Xoma royalty director Joseph Limber purchases shares worth $760,144 By Investing.com - Investing.com South Africa
Xoma royalty director Joseph Limber purchases shares worth $760,144 - Investing.com
XOMA (NASDAQ:XOMA) Rating Lowered to Sell at StockNews.com - Defense World
Top Executives Make Significant Moves in Xoma Stock! - TipRanks
Xoma royalty corp CFO buys $25k in depositary shares By Investing.com - Investing.com Canada
XOMA Royalty Corp’s chief investment officer acquires $26,200 in shares By Investing.com - Investing.com India
Xoma royalty corp CFO buys $25k in depositary shares - Investing.com
XOMA Royalty Corp Executives Increase Their Holdings - TradingView
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference - The Manila Times
Key Investment Insights: XOMA CIO Takes Stage at Major Healthcare Conference - Stock Titan
Charles Schwab Investment Management Inc. Grows Stock Position in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA stock touches 52-week low at $19.9 amid market shifts - Investing.com India
HC Wainwright Reiterates Buy Rating for XOMA (NASDAQ:XOMA) - Defense World
XOMA Co. (NASDAQ:XOMAO) Sees Significant Growth in Short Interest - The AM Reporter
H.C. Wainwright maintains Buy rating on XOMA with $104 target By Investing.com - Investing.com South Africa
The Analyst Verdict: XOMA Royalty In The Eyes Of 4 Experts - Benzinga
H.C. Wainwright maintains Buy rating on XOMA with $104 target - Investing.com
XOMA Co. (NASDAQ:XOMAO) Short Interest Up 110.7% in March - Defense World
Xoma royalty’s chief investment officer Bradley Sitko buys $98,751 in shares By Investing.com - Investing.com Australia
XOMA (NASDAQ:XOMA) Raised to Hold at StockNews.com - Defense World
HC Wainwright Estimates XOMA’s Q1 Earnings (NASDAQ:XOMA) - Defense World
HC Wainwright Reiterates “Buy” Rating for XOMA (NASDAQ:XOMA) - Defense World
Equities Analysts Set Expectations for XOMA FY2025 Earnings - Defense World
XOMA Royalty Declares Quarterly Preferred Stock Dividends - The Manila Times
Xoma Royalty Corp Stock (XOMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):